Cargando…

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets

Detalles Bibliográficos
Autores principales:	Blas-García, Ana, Cubero, Francisco Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687366/ https://www.ncbi.nlm.nih.gov/pubmed/36438803 http://dx.doi.org/10.3389/fphar.2022.1072353

Ejemplares similares

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease
por: Zhu, Shenghu, et al.
Publicado: (2020)

Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
por: Xu, Yu, et al.
Publicado: (2020)

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy
por: Li, Songtao, et al.
Publicado: (2022)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
por: Wang, Xue-Kai, et al.
Publicado: (2021)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease
por: Wei, Xiaoyi, et al.
Publicado: (2021)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants
por: Zhang, Wenji, et al.
Publicado: (2022)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Egea, Javier, et al.
Publicado: (2019)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
por: De Ternay, Julia, et al.
Publicado: (2019)

Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2023)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
por: Ji, Guang, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model
por: Chen, Xingtian, et al.
Publicado: (2018)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Identifying Candidate Flavonoids for Non-Alcoholic Fatty Liver Disease by Network-Based Strategy
por: Lee, Won-Yung, et al.
Publicado: (2022)

Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms
por: Ye, Shujun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aslpvhomq7jta5dqb6lhgt5fc7